Back

Montana approves experimental hearing-loss treatment under broad right-to-try law

Verifying
  • Montana's privately run review board approved Parley Neurotech's experimental hearing-loss treatment.
  • The treatment combines a daily antihistamine with 60 minutes of sound therapy for 30 days.
  • Montana requires approved therapies to pass Phase 1 trials and patient informed consent.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.